Oxidative stress and protective effect of erythropoietin on methotrexate-induced esophageal damage

Journal of Pediatric Hematology/Oncology

Volumn 32, Issue 2, 2010, Pages 108-112

  Garipardic, Mesut ^a   Bakan, Vedat ^a   Davutoǧlu, Mehmet ^a   Sayar, Hamide ^a   Kurutaş, Ergül Belge ^a  

^a KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

Author keywords

Erythropoietin; Esophagus; Methotrexate; Oxidative damage

Indexed keywords

CATALASE; ERYTHROPOIETIN; FREE RADICAL; MALONALDEHYDE; METHOTREXATE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; ENZYME ACTIVITY; ESOPHAGUS INJURY; FEMALE; HISTOPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ERYTHROPOIETIN; ESOPHAGUS; FEMALE; METHOTREXATE; MUCOSITIS; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77949460096     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181ccb678     Document Type: Article

References (36)

1. Radtke F, Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science. 2005;307:1904-1909.
2. Coeffier M, Claeyssens S, Hecketsweiler B, et al. Enteral glutamine stimulates protein synthesis and decreases ubiquitin mRNA level in human gut mucosa. Am J Physiol Gastrointest Liver Physiol. 2003;285:G266-G273.
3. Lalla RV, Schubert MM, Bensadoun RJ, et al. Anti-inflammatory agents in the management of alimentary mucositis. Support Care Cancer. 2006;14:558-565.
4. Leblond J, Le Pessot F, Hubert-Buron A, et al. Chemotherapyinduced mucositis is associated with changes in proteolytic pathways. Exp Biol Med (Maywood). 2008;233:219-228.
5. Günel E, Caǧ layan F, Caǧ layan O, et al. Reactive oxygen radical levels in caustic esophageal burns. J Pediatr Surg. 1999; 34:405-407.
6. Ishiyama F, Iijima K, Asanuma K, et al. Exogenous luminal nitric oxide exacerbates esophagus tissue damage in a reflux esophagitis model of rats. Scand J Gastroenterol. 2009;44: 527-537.
7. Lanas A, Soteras F, Jimenez P, et al. Superoxide anion and nitric oxide in high-grade esophagitis induced by acid and pepsin in rabbits. Dig Dis Sci. 2001;46:2733-2743.
8. Miyazono Y, Gao F, Horie T. Oxidative stress contributes to methotrexate-induced small intestinal toxicity in rats. Scand J Gastroenterol. 2004;39:1119-1127.
9. Wetscher GJ, Perdikis G, Kretchmar DH, et al. Esophagitis in Sprague-Dawley rats is mediated by free radicals. Dig Dis Sci. 1995;40:1297-1305.
10. Santhanam AV, Katusic ZS. Erythropoietin and cerebral vascular protection: role of nitric oxide. Acta Pharmacol Sin. 2006;27:1389-1394.
11. Jelkmann W. Erythropoietin after a century of research: younger than ever. Eur J Haematol. 2007;78:183-205.
12. Brines M, Cerami A. Discovering erythropoietin's extrahematopoietic functions: biology and clinical promise. Kidney Int. 2006;70:246-250.
13. Mori S, Sawada T, Okada T, et al. Erythropoietin and its derivative protect the intestine from severe ischemia/reperfusion injury in the rat. Surgery. 2008;143:556-565.
14. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351-358.
15. Lowry OH, Rosebrough NJ, Farr A. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265-275.
16. Fridovich I. Superoxide dismutase. Adv Enzymol. 1974;41: 35-97.
17. Beutler E. Red Cell Metabolism. 2nd ed. New York: Grune and Stratton Company; 1975:261-265.
18. Moshage H, Kok B, Huizenga JR, et al. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem. 1995;41:892-896.
19. Cortas NK, Wakid NW. Determination of inorganic nitratein serum and urine by akinetic cadmium reduction method. Clin Chem. 1990;36:1440-1443.
20. YüncüM, Eralp A, Celik A. Effect of aged garlic extract against methotrexate-induced damage to the small intestine in rats. Phytother Res. 2006;20:504-510.
21. Kumral A, Gonenc S, Acikgoz O, et al. Erythropoietin increases glutathione peroxidase enzyme activity and decreases lipid peroxidation levels in hypoxicischemic brain injury in neonatal rats. Biol Neonate. 2005;87:15-18.
22. Nagai A, Nakagawa E, Choi HB, et al. Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J Neuropathol Exp Neurol. 2001;60:386-392.
23. van der Vliet A, Eiserich JP, Halliwell B, et al. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxidedependent toxicity. J Biol Chem. 1997;272:7617-7625.
24. Ferdinandy P. Peroxynitrite: just an oxidative/nitrosative stressor or a physiological regulator as well? Br J Pharmacol. 2006;148:1-3.
25. Wink DA, Feelisch M, Vodovotz Y. The chemical biology of nitric oxide. In: Colton CA, Gilbert DL, eds. Reactive Oxygen Species in Biological Systems. New York: Kluwer Academic/ Plenum Publishing; 1999:245-291.
26. Ortega Mateo A, Amaya Aleixandre de Artiñano AA. Nitric oxide reactivity and mechanisms involved in its biological effects. Pharmacol Res. 2000;42:421-427.
27. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996;271:C1424-C1437.
28. Demchenko IT, Oury TD, Crapo JD, et al. Regulation of the brain's vascular responses to oxygen. Circ Res. 2002;91: 1031-1037.
29. Zelko IN, Folz RJ. Extracellular superoxide dismutase functions as a major repressor of hypoxia-induced erythropoietin gene expression. Endocrinology. 2005;146:332-340.
30. Joyeux-Faure M, Ramond A, Béguin PC, et al. Early pharmacological preconditioning by erythropoietin mediated by inducible NOS and mitochondrial ATP-dependent potassium channels in the rat heart. Fundam Clin Pharmacol. 2006; 20:51-56.
31. Sakanaka M, Wen TC, Matsuda S, et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA. 1998;95:4635-4640.
32. Marklund SL. Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem J. 1984;222:649-655.
33. Demarosi F, Bez C, Carrassi A. Prevention and treatment of chemo- and radiotherapy-induced oral mucositis. Minerva Stomatol. 2002;51:173-186.
34. Köstler WJ, Hejna M, Wenzel C, et al. Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment. CA Cancer J Clin. 2001;51: 290-315.
35. Sonis ST, Peterson RL, Edwards LJ, et al. Defining mechanisms of action of interleukin-11 on the progression of radiationinduced oral mucositis in hamsters. Oral Oncol. 2000;36: 373-381.
36. Gibson RJ, Keefe DM, Thompson FM, et al. Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats. Dig Dis Sci. 2002;47:2751-2757.